Why the study?
Serial conventional cardiac troponin measurements 6-9 hours apart are recommended for NSTEMI diagnosis, prompting the development of a 3-hour change pathway and assessment of the added value of the HEART score.
Does the Ottawa Troponin Pathway using conventional troponin I accurately identify 15-day MACE in adults presenting with NSTEMI symptoms?
Does the Ottawa Troponin Pathway using conventional troponin I accurately identify 15-day MACE in adults presenting with NSTEMI symptoms?
The Ottawa Troponin Pathway using conventional troponin I at 3-hour intervals provides high sensitivity and specificity for identifying 15-day MACE in patients with NSTEMI symptoms.
Answers are grounded in this paper and cite their sources.
May support Ottawa Troponin Pathway use in NSTEMI evaluation; leaves open need for prospective validation before practice change.
BACKGROUND: Serial conventional cardiac troponin (cTn) measurements 6-9 hours apart are recommended for non-ST-elevation MI (NSTEMI) diagnosis. We sought to develop a pathway with 3-hour changes for major adverse cardiac event (MACE) identification and assess the added value of the HEART [History, Electrocardiogram (ECG), Age, Risk factors, Troponin] score to the pathway. METHODS: We prospectively enrolled adults with NSTEMI symptoms at two-large emergency departments (EDs) over 32-months. Patients with STEMI, unstable angina and one cTn were excluded. We collected baseline characteristics, Siemens Vista conventional cTnI at 0, 3 or 6-hours after ED presentation; HEART score predictors; disposition and ED length of stay (LOS). Adjudicated primary outcome was 15-day MACE (acute MI, revascularization, or death due to cardiac ischemia/unknown cause). We analyzed multiples of 99th percentile cut-off cTnI values (45, 100 and 250ng/L). RESULTS: 1,683 patients (mean age 64.7 years; 55.3% female; median LOS 7-hours; 88 patients with 15-day MACE) were included. 1,346 (80.0%) patients with both cTnI≤45 ng/L; and 155 (9.2%) of the 213 patients with one value≥100ng/L but both<250ng/L or ≤20% change did not suffer MACE. Among 124 patients (7.4%) with one of the two values>45ng/L but<100ng/L based on 3 or 6-hour cTnI, one patient with absolute change<10ng/L and 6 of the 19 patients with≥20ng/L were diagnosed with NSTEMI (patients with Δ10-19ng/L between first and second cTnI had third one at 6-hours). Based on the results, we developed the Ottawa Troponin Pathway (OTP) with a 98.9% sensitivity (95% CI 93.8-100%) and 94.6% specificity (95% CI 93.3-95.6%). Addition of the HEART score improved the sensitivity to 100% (95% CI 95.9-100%) and decreased the specificity to 26.5% (95% CI 24.3-28.7%). CONCLUSION: The OTP with conventional cTnI 3-hours apart, should lead to better NSTEMI identification particularly those with values >99th percentile, standardize management and reduce the ED LOS.
No takes yet. Share an insight, caveat, or question.
Thiruganasambandamoorthy et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: